If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPTY.L Regulatory News (PTY)

  • There is currently no data for PTY

Director/PDMR Shareholding

18 Apr 2019 11:37

RNS Number : 6520W
Parity Group PLC
18 April 2019
 

18 April 2019

 

Parity Group plc ("Parity "or the "Group")

Grant of Options to Directors/PDMRs

 

The Board of Parity (AIM:PTY), the technology focussed consultancy and staffing business announces that the Board has awarded Matthew Bayfield, Chief Executive Officer 3,000,000 ordinary shares of 2 pence each in the Company ("Share Options"). The Share Options were granted on 18 April 2019 on the recommendation of the Remuneration Committee, and represent approximately 2.9% of the Company's current issued share capital.

 

The Share Options each have an exercise price, calculated in accordance with the rules of the Unapproved CSOP Scheme 2009, of 7.75 pence being the closing mid-market price per ordinary share on 17 April 2019.

 

The Share Options will vest after 3 years and are subject to the following performance conditions:

 

· One third of the Share Options will be exercisable if the share price achieves or exceeds 125% of the exercise price for a period of at least five consecutive trading days at any time during the vesting period;

· One third of the Share Options will be exercisable if the share price achieves or exceeds 150% of the exercise price for a period of at least five consecutive trading days at any time during the vesting period; and

· One third of the Share Options will be exercisable if the share price achieves or exceeds 175% of the exercise price for a period of at least five consecutive trading days at any time during the vesting period.

 

 

 

 

Contacts:

Parity Group PLC www.parity.net

Roger Antony, GFD + 44 (0) 208 543 5353

 

WH Ireland Limited www.whirelandcb.com

Mike Coe / Chris Savidge +44 (0) 207 220 1666

 

 

The notifications below, made in accordance with the EU Market Abuse Regulation, provide further details in relation to the grant of the Share Options to the PDMRs:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

Matthew Bayfield

2

 

Reason for the notification

a)

 

Position/status

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Parity Group plc

b)

 

LEI

213800YEHAYBJ63OHB38

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 2p each

 

GB00B1235860

b)

 

Nature of the transaction

 

Grant of options to subscribe for new ordinary shares under the Company's Unapproved CSOP Scheme 2009.

c)

 

Price(s) and volume(s)

 

Option Price(s)

 

Volume(s)

7.75p

3,000,000

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

- Price

 

 

 

3,000,000

 

£232,500.00

 

e)

 

Date of the transaction

18 April 2019

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHCKFDNKBKDPQD
Date   Source Headline
18th Jun 20103:22 pmRNSHolding(s) in Company
18th Jun 20103:15 pmRNSHolding(s) in Company
15th Jun 20101:16 pmRNSre Parity Training
10th Jun 20101:54 pmRNSDirector/PDMR Shareholding
2nd Jun 20105:21 pmRNSResult of AGM
24th May 20104:50 pmRNSHolding(s) in Company
24th May 20102:36 pmRNSHolding(s) in Company
24th May 20102:31 pmRNSHolding(s) in Company
20th May 20106:25 pmRNSHolding(s) in Company
20th May 20106:24 pmRNSHolding(s) in Company
19th May 20107:00 amRNSIMS & Board Changes
11th May 201011:24 amRNSPosting of Annual Financial Report
16th Apr 20107:00 amRNSRe Contract
14th Apr 20104:14 pmRNSHolding(s) in Company
30th Mar 20102:38 pmRNSHolding(s) in Company
25th Mar 20105:52 pmRNSHolding(s) in Company
23rd Mar 20107:00 amRNSFinal Results
17th Mar 20105:26 pmRNSHolding(s) in Company
9th Mar 20103:51 pmRNSNotice of Results
19th Jan 20102:00 pmRNSMinister anounces new centre of excellence
4th Dec 20097:00 amRNSTrading Statement
13th Nov 20097:00 amRNSInterim Management Statement
5th Nov 200911:21 amRNSHolding(s) in Company
20th Oct 20093:04 pmRNSDirector Declaration
29th Sep 20095:32 pmRNSAnnual Information Update
29th Sep 20095:22 pmRNSDoc re. Interim Report 2009
28th Aug 20097:00 amRNSHalf Yearly Report
18th Aug 200911:12 amRNSHolding(s) in Company
18th Aug 200911:09 amRNSHolding(s) in Company
10th Aug 200911:40 amRNSHolding(s) in Company
14th May 20091:10 pmRNSResult of AGM
14th May 200911:00 amRNSInterim Management Statement
16th Apr 20099:00 amRNSNotice of AGM/Annual Report
13th Mar 20093:50 pmRNSDirector/PDMR Shareholding
12th Mar 20097:00 amRNSFinal Results
2nd Mar 20097:00 amRNSCompletion of Disposal
24th Feb 20097:00 amRNSContract Renewal
19th Feb 200911:22 amRNSResult of EGM
2nd Feb 200912:04 pmRNSIssue of circular
29th Jan 20097:00 amRNSDisposal
22nd Jan 20094:40 pmRNSHolding(s) in Company
7th Jan 20093:50 pmRNSDirector Declaration
23rd Dec 20083:45 pmRNSDirector/PDMR Shareholding
4th Nov 20087:00 amRNSInterim Management Statement
1st Sep 200811:25 amRNSAnnual Information Update
29th Aug 20089:03 amRNSInterim Results (Replacement)
29th Aug 20087:00 amRNSInterim Results
26th Aug 20082:16 pmRNSDisposal Update
22nd Aug 200812:14 pmRNSDisposal Update
13th Aug 200811:47 amRNSResult of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.